700 Industrial Park Drive
Alabaster, AL 35007
1-800-227-0651 or 205-663-2494
Fax 1-800-229-1004 or 205-663-0756

OrdersTechnical QuestionsGeneral Information
the phospholipid people
OXIDIZED LIPIDS
We previously have demonstrated that oxidized 1-palmitoyl-2-arachidonoyl- sn-glycero-3-phosphorylcholine
(OxPAPC), a component of minimally modified low density lipoprotein (MM-LDL), activates endothelial cells to bind monocytes. 1-Palmitoyl-2- (5-oxovaleroyl)- sn-glycero-3-phosphorylcholine (POVPC) and 1- palmitoyl-2- glutaroyl- sn-glycero-3-phosphorylcholine (PGPC), which are present in OxPAPC, MM-LDL, and atherosclerotic lesions, were shown to have a major role in the activation of endothelial cells. We now demonstrate that thesetwo highly similar molecules have dramatically different effects on leukocyte endothelial interactions. POVPC is a potent regulator of monocyte-specific endothelial interactions. Treatment of endothelial cells with POVPCincreased monocyte binding by inducing the surface expression of the connecting segment 1 domain offibronectin; no increase in neutrophil binding was observed. In addition, POVPC strongly inhibitedlipopolysaccharide-mediated induction of neutrophil binding and expression of E-selectin protein and mRNA.This inhibition was mediated by a protein kinase A-dependent pathway, resulting in down-regulation of NF- kappaB-dependent transcription. In contrast, PGPC induced both monocyte and neutrophil binding and
expression of E-selectin and vascular cell adhesion molecule 1. We present evidence to suggest that the two phospholipids act by different novel receptors present in Xenopus laevis oocytes and that POVPC, but not PGPC, stimulates a cAMP-mediated pathway. At concentrations equal to that present in MM-LDL, the effect of POVPC dominates and inhibits PGPC-induced neutrophil binding and E-selectin expression in endothelial cells. In summary, our data provide evidence that both POVPC and PGPC are important regulators of leukocyte- endothelial interactions and that POVPC may play a dominant role in a number of chronic inflammatory processes where oxidized phospholipids are known to be present.
Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils.

REFERENCES
      (1999). Leitinger, N., T.R. Tyner, L. Oslund, C. Rizza, G. Subbanagounder, H. Lee, P.T. Shih, N. Mackman, G. Tigyi, M.C. Territo, J.A. Berliner, and D.K. Vora.Structurally similar oxidized phospholipids differentially regulate endothelial binding of monocytes and neutrophils.
      Proc Natl Acad Sci. Oct 12;96(21):12010-5. [PubMed]
16:0-09:0(COOH)PC
1-Palmitoyl-2-Azelaoyl-sn-Glycero-3-Phosphocholine  

Catalog Number
Molecular Weight
 
870600
665.85
Learn More


C16-09:0(COOH)PC
1-O-Hexadecyl-2-Azelaoyl-sn-Glycero-3-Phosphocholine  

Catalog Number
Molecular Weight
 
870601
651.86
Learn More


16:0-05:0 (COOH) PC
1-Palmitoyl-2-Glutaroyl-sn-Glycero-3-Phosphocholine (PGPC)  

Catalog Number
Molecular Weight
Purity
 
870602
609.74
>99%
Learn More


16:0-09:0(ALDO)PC
1-Palmitoyl-2-(9'-oxo-Nonanoyl)-sn-Glycero-3-Phosphocholine  

Catalog Number
Molecular Weight
Purity
 
870605
649.85
>99%
Learn More


16:0-05:0 (ALDO) PC (POVPC)
1-Palmitoyl-2-(5'-oxo-Valeroyl)-sn-Glycero-3-Phosphocholine  

Catalog Number
Molecular Weight
Purity
 
870606
593.74
>99%
Learn More



© Avanti Polar Lipids, Inc. All rights reserved.
Terms of Use | Privacy Policy | Comments